Cleared Traditional

K981103 - TURBOSONICS LIMITED REUSE ULTRASONIC TIP

K981103 is an FDA 510(k) clearance for TURBOSONICS LIMITED REUSE ULTRASONIC TIP, manufactured by Alcon Laboratories. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 89-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1998
Decision
89d
Days
Class 2
Risk

K981103 is an FDA 510(k) clearance for the TURBOSONICS LIMITED REUSE ULTRASONIC TIP. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Alcon Laboratories (Fort Worth, US). The FDA issued a Cleared decision on June 23, 1998 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Alcon Laboratories devices

FDA 510(k) Submission Details - K981103

510(k) Number K981103 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 1998
Decision Date June 23, 1998
Days to Decision 89 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 110d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 191
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K981103.
OCUSYSTEM ART ADVANTAGE, MODEL 995
K991852 · Surgical Design Corp. · Jul 1999
FIBRA-SONICS PHACO III OR IIIP FRAGMENTATION SYSTEM
K984143 · Fibra Sonics, Inc. · Feb 1999
THE WAVE DIGITAL PHACO SYSTEM
K981989 · Circuit Tree · Aug 1998
QUITETIP
K981109 · Paradigm Medical Industries, Inc. · Jun 1998
SYNTEC VITMAN
K980480 · Syntec, Inc. · May 1998
MENTOR PHACOEMULSIFICATION SISTEM REMOTE CONTROL
K974469 · Mentor Corp. · Feb 1998